Literature DB >> 227692

The sensitivity of scintigraphic myocardial imaging by the use of 99mTc-labelled pyrophosphate in the diagnosis of cardiomyopathy of various etiology.

F Duska, J Vizda, J Kubícek, P Kafka, Z Nesvadba, P Zdánský, J Bastecký.   

Abstract

A total of 10 patients were examined. In five children who suffered from secondary cardiomyopathy accompanying progressive muscular dystrophy scintigraphic examination of the myocardium was made using 99mTc-labelled pyrophosphate. In two cases the scan was distinctly positive, in three cases negative. Five men with poorly defined primary nonobstructive cardiomyopathy were examined too. The scan was positive in three cases and negative in two cases. The positivity of the pyrophosphate scan of the heart is therefore not pathonomonic of ischaemic damage. An increased accumulation of pyrophosphate in the myocardium in cardiomyopathy indicates an acute phase of the disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 227692     DOI: 10.1007/BF00626076

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


  14 in total

1.  Progressive muscular dystrophy of the heart.

Authors:  O STORSTEIN; K AUSTARHEIM
Journal:  Acta Med Scand       Date:  1955

2.  Acute subendocardial myocardial infarction in patients. Its detection by Technetium 99-m stannous pyrophosphate myocardial scintigrams.

Authors:  J T Willerson; R W Parkey; F J Bonte; S L Meyer; E M Stokely
Journal:  Circulation       Date:  1975-03       Impact factor: 29.690

3.  Cardiac involvement in progressive muscular dystrophy.

Authors:  S WEISENFELD; W J MESSINGER
Journal:  Am Heart J       Date:  1952-02       Impact factor: 4.749

4.  [Acute infarction of the myocardium in man. scintigraphic diagnosis using pyrophosphate designated 99m tc (author's transl)].

Authors:  F Duska; J Vizda; J Kubícek; J Trcka; P Kafka
Journal:  Cas Lek Cesk       Date:  1976-09-03

5.  A new method for radionuclide imaging of myocardial infarcts.

Authors:  F J Bonte; R W Parkey; K D Graham; J Moore; E M Stokely
Journal:  Radiology       Date:  1974-02       Impact factor: 11.105

6.  Localization of myocardial disorders other than infarction with 99mTc-labeled phosphate agents.

Authors:  L A Perez; D B Hayt; L M Freeman
Journal:  J Nucl Med       Date:  1976-04       Impact factor: 10.057

7.  Unstable angina pectoris. Clinical, angiographic, and myocardial scintigraphic observations.

Authors:  M S Donsky; G C Curry; R W Parkey; S L Meyer; F J Bonte; M R Platt; J T Willerson
Journal:  Br Heart J       Date:  1976-03

8.  Detection of acute myocardial infarction by technetium-99m polyphosphate.

Authors:  P McLaughlin; G Coates; D Wood; T Cradduck; J Morch
Journal:  Am J Cardiol       Date:  1975-03       Impact factor: 2.778

9.  The specificity of the diffuse pattern of cardiac uptake in myocardial infarction imaging with technetium-99m stannous pyrophosphate.

Authors:  R Prasquier; M R Taradash; E H Botvinick; D M Shames; W W Parmley
Journal:  Circulation       Date:  1977-01       Impact factor: 29.690

10.  Pathophysiology of technetium-99m stannous pyrophosphate and thallium-201 scintigraphy of acute anterior myocardial infarcts in dogs.

Authors:  L M Buja; R W Parkey; E M Stokely; F J Bonte; J T Willerson
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

View more
  2 in total

1.  The sensitivity of scintigraphic myocardial imaging by the use of 99mTc-labelled pyrophosphate in the diagnosis of cardiomyopathy of various etiology.

Authors:  F Duska; J Vizda; J Kubícek; P Kafka; Z Nesvadba; P Zdánský; J Bastecký
Journal:  Eur J Nucl Med       Date:  1979-04-01

2.  Pyrophosphate heart scan in patients with progressive systemic sclerosis.

Authors:  F Duska; P Bradna; J Novák; J Kubícek; J Vizda; P Kafka; Y Mazurová; V Blaha
Journal:  Br Heart J       Date:  1982-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.